<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00724945</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1485CK</org_study_id>
    <nct_id>NCT00724945</nct_id>
  </id_info>
  <brief_title>Comparison of Two Soft Bifocal Contact Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare the visual performance of two soft bifocal contact
      lenses.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">August 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Distance Visual Acuity</measure>
    <time_frame>after 1 week of wear</time_frame>
    <description>This outcome measures vision while subjects are looking at objects in the distance and is measures in logMARs.logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Near Visual Acuity</measure>
    <time_frame>after 1 week wear</time_frame>
    <description>This outcome measures vision while subjects are looking at objects near to them and is measured in logMARs. logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Subject Vision</measure>
    <time_frame>after 1 week wear</time_frame>
    <description>Subjects responded to &quot;How would you rate the overall quality of vision with these study contact lenses&quot; using the following scale: 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">113</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>senofilcon A / balafilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>senofilcon A multifocal lenses worn first, balafilcon A multifocal lenses worn second</description>
  </arm_group>
  <arm_group>
    <arm_group_label>balafilcon A/senofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>balafilcon A multifocal lenses worn first, senofilcon A multifocal lenses worn second</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>balafilcon A</intervention_name>
    <description>multifocal contact lens</description>
    <arm_group_label>senofilcon A / balafilcon A</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A</intervention_name>
    <description>multifocal contact lens</description>
    <arm_group_label>senofilcon A / balafilcon A</arm_group_label>
    <arm_group_label>balafilcon A/senofilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject must between 35 and 70 years of age.

          -  The subject must have presbyopic symptoms or be already wearing presbyopic contact
             lens correction.

          -  The subject's spherical equivalent distance refraction must be in the range of -1.00
             to -6.00 or -9.00 to -10.00 in each eye.

          -  Refractive cylinder must be -0.75 D in each eye.

          -  The subject must have an ADD power of +0.75D to +2.50D in each eye.

          -  The subject must have best corrected visual acuity of 20/20-3 or better in each eye

          -  The subject's must have at least 20/30-distance vision OU with the study contact
             lenses.

          -  The subject must agree that they are comfortable with their vision prior to being
             dispensed the study lenses

          -  The subject must be an adapted soft contact lens wearer in both eyes.

          -  The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

          -  The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a
             copy of the form.

        Exclusion Criteria:

          -  Ocular or systemic allergies or disease that may interfere with contact lens wear.

          -  Systemic disease, autoimmune disease or use of medication, which may interfere with
             contact lens wear.

          -  Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal
             staining or any other abnormality of the cornea, which may contraindicate contact lens
             wear

          -  Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with
             contact lens wear.

          -  Any ocular infection.

          -  Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          -  Pregnancy or lactation

          -  Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease
             (e.g., HIV).

          -  History of diabetes

          -  History of binocular vision abnormality or strabismus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Dr. James Weber &amp; Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ted Brink &amp; Associates</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eye Associates of Winter Park</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lee Rigel</name>
      <address>
        <city>East Lansing</city>
        <state>Michigan</state>
        <zip>48823</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Timothy R. Poling, OD</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24153</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2008</study_first_submitted>
  <study_first_submitted_qc>July 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <results_first_submitted>September 25, 2009</results_first_submitted>
  <results_first_submitted_qc>December 23, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 27, 2010</results_first_posted>
  <last_update_submitted>May 5, 2015</last_update_submitted>
  <last_update_submitted_qc>May 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Senofilcon A/Balafilcon A</title>
          <description>senofilcon A multifocal contact lenses worn first, balafilcon A multifocal contact lenses worn second</description>
        </group>
        <group group_id="P2">
          <title>Balafilcon A/Senofilcon A</title>
          <description>balafilcon A multifocal contact lenses worn first/ senofilcon A multifocal contact lenses worn second</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Period 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="55"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>non-compliance</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Period 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>lens comfort issue</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>lens physiology issue</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Overall</title>
          <description>The reporting group for baseline characteristics includes all subjects that completed the study wearing contact lenses made from either senofilcon A or balafilcon A material. Excluded are 8 subjects that discontinued and 2 subjects dispensed lenses from outside study contact lens materials.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="103"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.2" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Distance Visual Acuity</title>
        <description>This outcome measures vision while subjects are looking at objects in the distance and is measures in logMARs.logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal</description>
        <time_frame>after 1 week of wear</time_frame>
        <population>Analysis includes participants who completed the study per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>multifocal contact lens</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A</title>
            <description>multifocal contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Distance Visual Acuity</title>
          <description>This outcome measures vision while subjects are looking at objects in the distance and is measures in logMARs.logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal</description>
          <population>Analysis includes participants who completed the study per protocol.</population>
          <units>logMAR units</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="103"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.08591" spread="0.008816"/>
                    <measurement group_id="O2" value="-0.10267" spread="0.008855"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: senofilcon A multifocal would be better than or equal to 0.1 logMAR units.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Least Square Mean</param_type>
            <param_value>-0.08591</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.008816</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_lower_limit>-0.08591</ci_lower_limit>
            <ci_upper_limit>-0.06857</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Near Visual Acuity</title>
        <description>This outcome measures vision while subjects are looking at objects near to them and is measured in logMARs. logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal.</description>
        <time_frame>after 1 week wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>multifocal contact lens</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A</title>
            <description>multifocal contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Near Visual Acuity</title>
          <description>This outcome measures vision while subjects are looking at objects near to them and is measured in logMARs. logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values &gt;0.00 indicate vision poorer than ideal and values&lt;0.0 indicate vision greater than ideal.</description>
          <units>logMAR units</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="103"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.02711" spread="0.008816"/>
                    <measurement group_id="O2" value="0.01933" spread="0.008861"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: senofilcon A multifocal lens would be better than or equal to 0.17 logMAR units.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <param_type>Least Square Mean</param_type>
            <param_value>0.02711</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.008816</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_lower_limit>0.02711</ci_lower_limit>
            <ci_upper_limit>0.04445</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Subject Vision</title>
        <description>Subjects responded to &quot;How would you rate the overall quality of vision with these study contact lenses&quot; using the following scale: 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.</description>
        <time_frame>after 1 week wear</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Senofilcon A</title>
            <description>multifocal contact lens</description>
          </group>
          <group group_id="O2">
            <title>Balafilcon A</title>
            <description>multifocal contact lens</description>
          </group>
        </group_list>
        <measure>
          <title>Subject Vision</title>
          <description>Subjects responded to &quot;How would you rate the overall quality of vision with these study contact lenses&quot; using the following scale: 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.</description>
          <units>Scores on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="103"/>
                <count group_id="O2" value="103"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.4594" spread="0.09926"/>
                    <measurement group_id="O2" value="3.3853" spread="0.09926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Alternative hypothesis: senofilcon A multifocal lens will have subjective vision that is non-inferior to balafilcon A multifocal.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The non-inferiority margin is -0.5.</non_inferiority_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.07407</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.1279</dispersion_value>
            <ci_percent>97.5</ci_percent>
            <ci_lower_limit>-0.1797</ci_lower_limit>
            <ci_upper_limit>0.07407</ci_upper_limit>
            <estimate_desc>Mean difference was calculated as senofilcon A multifocal minus balafilcon A multifocal.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Senofilcon A/Balafilcon A</title>
          <description>senofilcon A multifocal contact lenses worn first, balafilcon A multifocal contact lenses worn second</description>
        </group>
        <group group_id="E2">
          <title>Balafilcon A/Senofilcon A</title>
          <description>balafilcon A multifocal contact lenses worn first/ senofilcon A multifocal contact lenses worn second</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="58"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="55"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The PI may not publish, divulge, reveal, disclose, or use the data and or results of the study without prior written consent of Vistakon.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Thomas Karkkainen OD</name_or_title>
      <organization>Vistakon</organization>
      <phone>904-443-3402</phone>
      <email>tkarkkai@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

